MedPath

Camparison Effects of Autologous Conditioned Serum, platelet rich plasma and Prolotherapy in treatment of Knee osteoarthritis

Phase 3
Conditions
Knee osteoartritis.
Osteoarthritis of knee
Registration Number
IRCT20100720004422N6
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Age between 40-75
Grade I-II-III of OA (Kellgren-Lawrence)
Pain severity >4 in a 10-numbered linear scale
Pain in more than 3 months

Exclusion Criteria

Grade IV of OA
Multifactorial Knee Pain
Lower limb Deformity

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Functional condition. Timepoint: At the beginning of the study(before the intervention) ? one and six months after treatment. Method of measurement: Western Ontario and McMaster (WOMAC) questionair.;Pain severity. Timepoint: Visual Analogue Scale (VAS) and Western Ontario and McMaster (WOMAC) questionnaire. Method of measurement: At the beginning of the study(before the intervention) and one and six months after treatment.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath